Acutus Medical Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2024 to a ratio of 2.3, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Acutus Medical Inc in Dec 31 2024 quarter, has decreased to 159 days, compared to 263 days, in the Sep 30 2024 quarter.

If we take a look into Healthcare sector 501 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2024 from 3429 to 3436.

What is Receivable Turnover Ratio?
What is Acutus Medical Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AFIB Receivables Turnover Ratio	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Receivable Change	-30.61 %	11.37 %	20.4 %	45.13 %	-46.16 %
Y / Y Revenue Change	283.9 %	-5.84 %	-	-28.78 %	-52.68 %
Receivable Turnover Ratio (TTM)	2.3	1.39	1.46	1.12	1.34
AFIB's Total Ranking	# 3436	# 3429	# 806	# 0	# 0
Accounts Receivable average collection period days	159	262	250	327	272
Seq. Receivable Change	-20.98 %	7.96 %	19.16 %	-31.74 %	26.82 %
Seq. Revenue Change	106.18 %	19.55 %	23.13 %	26.49 %	-49.43 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 175
Healthcare Sector	# 502
Overall Market	# 3436

Receivable Turnover Ratio Statistics
High	Average	Low
5.57	3.89	1.94
(Sep 30 2022)		(Mar 31 2021)

AFIB Company Profile • Back to AFIB Efficiency Comparisons • Compare AFIB Receivables Turnover Ratio to its Competitors

Financial Statements
Acutus Medical Inc 's Accounts Receivable	$ 8 Millions	Visit AFIB's Balance sheet
Acutus Medical Inc 's Sales TTM	$ 20 Millions	Visit AFIB's Income Statement
Sources of AFIB's Revenues		Visit AFIB's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AFIB's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AFIB's Growth Rates	AFIB's Roa	AFIB's Inventory Turnover Ratio	AFIB's Dividend Comparisons
AFIB's Profitability Ratios	AFIB's Roi	AFIB's Asset Turnover Ratio	AFIB's Dividend Growth
AFIB's Valuation Ratios	AFIB's Roe	AFIB's Financial Strength Ratios	AFIB's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2024	Receivable at quarter ending Dec 31 2024
Castle Biosciences Inc	6.98	$ 332.069 Millions	$ 47.542 Millions
Integer Holdings Corporation	6.97	$ 1,716.014 Millions	$ 246.193 Millions
Treace Medical Concepts Inc	6.94	$ 209.357 Millions	$ 30.155 Millions
Myriad Genetics Inc	6.94	$ 837.400 Millions	$ 120.700 Millions
Hca Healthcare Inc	6.90	$ 70,603.000 Millions	$ 10,237.250 Millions
Beone Medicines Ltd	6.89	$ 3,808.712 Millions	$ 552.517 Millions
Boston Scientific Corporation	6.86	$ 16,747.000 Millions	$ 2,440.750 Millions
Zoetis Inc	6.85	$ 9,256.000 Millions	$ 1,350.750 Millions
Bioxcel Therapeutics Inc	6.85	$ 2.266 Millions	$ 0.331 Millions
Bionexus Gene Lab Corp	6.83	$ 9.511 Millions	$ 1.392 Millions
Volitionrx Limited	6.82	$ 1.234 Millions	$ 0.181 Millions
Merit Medical Systems Inc	6.81	$ 1,356.333 Millions	$ 199.164 Millions
Tela Bio Inc	6.79	$ 68.488 Millions	$ 10.093 Millions
Lakeland Industries Inc	6.77	$ 167.211 Millions	$ 24.717 Millions
Harvard Bioscience Inc	6.76	$ 93.766 Millions	$ 13.873 Millions
Si bone inc	6.73	$ 167.121 Millions	$ 24.818 Millions
Interpace Biosciences Inc	6.72	$ 45.431 Millions	$ 6.762 Millions
Carlisle Companies Incorporated	6.71	$ 5,003.600 Millions	$ 745.825 Millions
Edwards Lifesciences Corporation	6.69	$ 5,439.000 Millions	$ 812.550 Millions
Neuropace Inc	6.69	$ 79.085 Millions	$ 11.821 Millions
Phibro Animal Health Corporation	6.69	$ 1,105.115 Millions	$ 165.192 Millions
Pacira Biosciences inc	6.67	$ 700.966 Millions	$ 105.094 Millions
Teleflex Incorporated	6.67	$ 3,046.679 Millions	$ 456.795 Millions
10x Genomics Inc	6.66	$ 610.482 Millions	$ 91.635 Millions
Neuroone Medical Technologies Corp	6.66	$ 6.455 Millions	$ 0.970 Millions
Puma Biotechnology Inc	6.62	$ 230.468 Millions	$ 34.836 Millions
Ufp Technologies Inc	6.60	$ 503.693 Millions	$ 76.367 Millions
Haemonetics Corporation	6.59	$ 1,372.814 Millions	$ 208.383 Millions
Prestige Consumer Healthcare Inc	6.58	$ 1,118.270 Millions	$ 169.823 Millions
Paragon 28 inc	6.57	$ 255.489 Millions	$ 38.883 Millions

Date modified: 2026-08-29T01:53:14+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.